MedTrace Logo

Vitamin D Supplementation to Obese Chinese Males

NCT01781169 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2013-10-30

Study results available
· View outcomes & findings →

Summary

Hypothesis: Oral Supplementation of Vitamin D can Reduce Hypersecretion of Parathyroid Hormone and Insulin Resistance in Obese Chinese Males.

Protocol: Weekly oral supplementation of 50,000 IU vitamin D (cholecalciferol) or eight weeks to the obese males compared with the normal-weight males. Index measures were conducted at baseline and endpoint.

Conditions

Interventions

DIETARY_SUPPLEMENT

Oral supplementation of vitamin D

Weekly oral supplementation of 50,000 IU vitamin D (cholecalciferol) for eight weeks to the obese males compared with the normal-weight males. The chemical form of vitamin D is cholecalciferol capsuled as fine powder.

Sponsors & Collaborators

  • Danone Institute China Diet Nutrition Research and Communication

    collaborator UNKNOWN

  • Shenzhen Center for Chronic Disease Control

    lead OTHER

Principal Investigators

  • Ji-Chang Zhou, Ph.D · Shenzhen Center for Chronic Disease Control

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
23 Years
Max Age
66 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-12-31
Completion
2012-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01781169 on ClinicalTrials.gov